Masakazu Nagata

Papers

Total Citations

H-Index

About

Dr. Masakazu Nagata is a leading urologic oncologist whose research focuses on improving surgical outcomes and preoperative risk stratification for prostate cancer, particularly through robotic-assisted techniques. His major contributions center on refining predictive models for disease staging to enhance surgical planning and patient counseling. In his highly cited work, Nagata identified key preoperative factors—such as biopsy Gleason score, prostate-specific antigen levels, and clinical T stage—that independently predict seminal vesicle invasion (pT3b) in patients undergoing robot-assisted radical prostatectomy (RARP). This research directly addresses the critical challenge of unexpected pathological upstaging, which can alter prognosis and treatment decisions. By enabling more accurate preoperative risk assessment, his findings help surgeons anticipate complex cases and tailor surgical approaches, potentially reducing positive margins and improving oncologic control. Nagata’s work has garnered significant attention, with his seminal paper accumulating over 100 citations, underscoring its impact on clinical practice. His contributions are instrumental in advancing precision medicine in urologic oncology, bridging the gap between imaging, biopsy data, and surgical outcomes to optimize patient care.